| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 04/15/2010 | US20100093830 Modulation of MLCK-L Expression and Uses Thereof |
| 04/15/2010 | US20100093820 Crystalline pyrazoles |
| 04/15/2010 | US20100093819 Phenylpropionic acid derivative and use thereof |
| 04/15/2010 | US20100093806 Phosphodiesterase 4 inhibitors, including aminoindazole and aminobenzofuran analogs |
| 04/15/2010 | US20100093802 Ccr9 inhibitors and methods of use thereof |
| 04/15/2010 | US20100093798 Cyclic modulators of chemokine receptor activity |
| 04/15/2010 | US20100093788 Heterocyclic benzimidazoles as trpm8 modulators |
| 04/15/2010 | US20100093785 Diamine derivatives |
| 04/15/2010 | US20100093782 Pyrazolonaphthyridine derivatives |
| 04/15/2010 | US20100093774 5-substituted quinazolinone derivatives and compositions comprising and methods of using the same |
| 04/15/2010 | US20100093767 Mitotic Kinase Inhibitors |
| 04/15/2010 | US20100093749 Compounds |
| 04/15/2010 | US20100093747 Method of inducing negative chemotaxis |
| 04/15/2010 | US20100093740 5,6,7,8-tetrahydro-imidazo[1,5-a]pyrazine derivatives |
| 04/15/2010 | US20100093725 Semi-solid formulations of phospholipase enzyme inhibitors |
| 04/15/2010 | US20100093713 Beta-carbolines useful for treating inflammatory disease |
| 04/15/2010 | US20100093712 Two-component pharmaceutical composition for the treatment of pain |
| 04/15/2010 | US20100093708 Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use |
| 04/15/2010 | US20100093690 5-phenylthiazole derivatives and use as pi3 kinase inhibitors |
| 04/15/2010 | US20100093688 Porphyrin catalysts and methods of use thereof |
| 04/15/2010 | US20100093677 Method of inducing negative chemotaxis |
| 04/15/2010 | US20100093673 Pain relieving patch |
| 04/15/2010 | US20100093671 Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use |
| 04/15/2010 | US20100093632 Enamel matrix protein composition for treatment of systemic inflammatory response |
| 04/15/2010 | US20100093628 Methods of treatment using wisp polypeptides |
| 04/15/2010 | US20100093623 Compositions and methods for modulating nod-like receptor activity and uses thereof |
| 04/15/2010 | US20100092997 Method of Enhancing of Binding Activity of Antibody Composition to FcGamma Receptor IIIa |
| 04/15/2010 | US20100092569 Product based on conjugated linoleic acid and a method for the manufacture thereof |
| 04/15/2010 | US20100092555 Soft tablet containing high molecular weight cellulosics |
| 04/15/2010 | US20100092545 Polyethylene-oxide based films and drug delivery systems made therefrom |
| 04/15/2010 | US20100092493 Modulation of Complement System Activation for Treatment of Bleeding-Related Inflammation |
| 04/15/2010 | US20100092486 Modulation of myeloid differentation primary response gene 88 (myd88) expression by antisense oligonucleotides |
| 04/15/2010 | US20100092484 Cd44 antibodies |
| 04/15/2010 | US20100092462 Methods for Suppressing Toll-Like Receptor Activity |
| 04/15/2010 | US20100092436 Compositions and methods for restoring immune responsiveness in patients with immunological defects |
| 04/15/2010 | US20100092434 Thrombopoietic activity of tyrosyl-trna synthetase polypeptides |
| 04/15/2010 | CA2740003A1 Pyrone analogs for therapeutic treatment |
| 04/15/2010 | CA2738630A1 Methods for treating or preventing pain using spicamycin derivatives |
| 04/15/2010 | CA2736097A1 Carbazole compounds and therapeutic uses of the compounds |
| 04/14/2010 | EP2174954A1 Hematopoietic cell e-selection/l-selectin ligand polypeptides and methods of use thereof |
| 04/14/2010 | EP2174949A2 Leucine-based motif and clostridial neurotoxins |
| 04/14/2010 | EP2174667A1 Agent for treatment of ophthalmia containing interleukin-6 receptor inhibitor as active ingredient |
| 04/14/2010 | EP2174659A1 Substituted indeno[1,2-c]isoquinoline derivatives and uses thereof |
| 04/14/2010 | EP2173733A2 Compositions and methods comprising analogues of radicicol a |
| 04/14/2010 | EP2173715A2 Use of piperidine derivatives as agonists of chemokine receptor activity |
| 04/14/2010 | EP2173713A2 Piperidinyl derivatives as modulators of chemokine receptor activity |
| 04/14/2010 | EP2173438A2 Treatments and diagnostics for cancer, inflammatory disorders and autoimmune disorders |
| 04/14/2010 | EP2173381A2 Fc receptor-binding polypeptides with modified effector functions |
| 04/14/2010 | EP2173339A1 Campsiandra angustifolia extract and methods of extracting and using such extract |
| 04/14/2010 | EP2173170A2 Fused heterocycles |
| 04/14/2010 | EP1805170B1 Mif-inhibitors |
| 04/14/2010 | EP1599201B1 Selective non-steroidal glucocorticoid receptor modulators |
| 04/14/2010 | EP1507533B1 Heteroaryl compounds which inhibit leukocyte adhesion mediated by alpha-4 integrins |
| 04/14/2010 | EP1477482B1 Novel phenylalanine derivative |
| 04/14/2010 | EP1409016B1 Antibodies to opgl |
| 04/14/2010 | EP1400515B1 Cyclic diamine compound having five-membered cyclic group |
| 04/14/2010 | CN1985915B Chinese medicine for treating diabetes complicated peripheral neuropathy |
| 04/14/2010 | CN1968694B An analgesic pharmaceutical composition |
| 04/14/2010 | CN1939325B Medicinal composition of houttuynin sodium and astragalin, its making method and usage |
| 04/14/2010 | CN1887317B Externally applied liniment for treating rheumatic and rheumatoid arthritis and its preparation |
| 04/14/2010 | CN1739655B Quality control method of Qingkailing injection preparation |
| 04/14/2010 | CN101693731A Method for extracting purified plantarenaloside from herba lysimachiae, product of plantarenaloside and application of method |
| 04/14/2010 | CN101693091A Prescription of pain relieving physiotherapy bag |
| 04/14/2010 | CN101693076A Content measuring method of vitexin in tropaeolum heat-clearing granules |
| 04/14/2010 | CN101693073A Compound caesalpinia pulcherrima spraying agent and preparation method thereof |
| 04/14/2010 | CN101693069A External preparation for treating soft tissue injuries and preparation method thereof |
| 04/14/2010 | CN101693065A Medicament for treating polymyalgia rheumatica and preparation method thereof |
| 04/14/2010 | CN101693058A Medicament for preventing and treating cold and inflammation infection |
| 04/14/2010 | CN101693056A External medicine bag for treating articular osteoid diseases and using method thereof |
| 04/14/2010 | CN101693051A Preparation method and composition of clerodendranthus spicatus extract |
| 04/14/2010 | CN101693049A Sambucus chinensis extract and preparation method thereof |
| 04/14/2010 | CN101693032A Composition for treating feline infectious anaemia and method for preparing the composition |
| 04/14/2010 | CN101693030A External medicine composition used for relieving pain and preparation method thereof |
| 04/14/2010 | CN101693022A Method for preparing resveratrol sustained-release capsule capable of preventing rheumatoid arthritis |
| 04/13/2010 | US7696313 Prodrug compounds with isoleucine |
| 04/13/2010 | US7696172 culture product produced by culturing a recombinant host cell under suitable conditions to express the polypeptide; has an oncogenic activity; treating liver disorder cirrhosis, or pancreas disorder |
| 04/13/2010 | US7696157 Plurality of isolated erythropoietin-like molecules; reperfusion injuries; antiischemic, antihypoxic, antiinflammatory gents; neurodegenerative or nervous system disorders; genetic engineering and expression |
| 04/13/2010 | US7695940 Gamma-1 and gamma-3 anti-human CD23 monoclonal antibodies and use thereof as therapeutics |
| 04/13/2010 | US7695741 Cavalia gladiata, Biota orientalis and Coptis chinensis very effective in prevention and treatment of acnes and have very little or no irritation; microbiocides; sebum ihibitors; keratolysis; antiinflammatory agents; enzyme inhibitors of 5-alpha-reductase; Chinese herbal medicine |
| 04/13/2010 | US7695736 Powder of 30-90% a water-soluble cycloxygenase inhibitor, 5-60% of a buffer and 0-10% of other excipients |
| 04/13/2010 | US7695720 target VEGFR2 (KDR/flk-1); for treating and preventing tumors |
| 04/13/2010 | CA2432303C Pyrazole compounds useful as protein kinase inhibitors |
| 04/13/2010 | CA2431308C Regulation of angiogenesis with zinc finger proteins |
| 04/13/2010 | CA2430363C Compounds and their uses |
| 04/13/2010 | CA2422377C Pyrazole compounds useful as protein kinase inhibitors |
| 04/13/2010 | CA2407683C Topical anesthetic/opioid formulations and uses thereof |
| 04/13/2010 | CA2399208C Nucleoside analogs with carboxamidine modified monocyclic base |
| 04/13/2010 | CA2360680C Antioxidant compositions and methods for companion animals |
| 04/13/2010 | CA2321268C Liquid crystal forms of cyclosporin |
| 04/13/2010 | CA2189015C Methods and compositions for the treatment of glomerulonephritis and other inflammatory diseases |
| 04/08/2010 | WO2010040055A2 Oral pharmaceutical formulations for antidiabetic compounds |
| 04/08/2010 | WO2010040054A2 Methods for suppressing toll-like receptor activity |
| 04/08/2010 | WO2010039861A2 Dendrimer conjugates |
| 04/08/2010 | WO2010039237A1 Compounds for inflammation and immune-related uses |
| 04/08/2010 | WO2010039236A1 Compounds for inflammation and immune-related uses |
| 04/08/2010 | WO2010039186A2 Compounds useful as faah modulators and uses thereof |
| 04/08/2010 | WO2010038840A1 METHOD FOR PREDICTING PHARMACOLOGICAL EFFICACY OF ANTI-TNFα ANTIBODY PREPARATION ON RHEUMATOID ARTHRITIS, AND PHARMACOLOGICAL EFFICACY PREDICTION APPARATUS |
| 04/08/2010 | WO2010038610A1 Novel cartilage cell proliferation and differentiation inducer |
| 04/08/2010 | WO2010038465A1 8-substituted isoquinoline derivative and use thereof |
| 04/08/2010 | WO2010038434A1 Process for production of optically active hexahydropyrroloquinoline and intermediate for the process |